- Title
- The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal
- Creators
- Kelly H SKELTON - Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, United StatesDavid A GUTMAN - Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, United StatesK. V THRIVIKRAMAN - Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, United StatesCharles B NEMEROFF - Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, United StatesMichael J OWENS - Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, United States
- Publication Details
- Psychopharmacologia, Vol.192(3), pp.385-396
- Publisher
- Springer; Berlin
- Academic Unit
- UMMG Dept of Psychiatry & Behavioral Sciences
- Language
- English
- Resource Type
- Journal article
- PMID
- 17297634
- Record Identifier
- 991031559516802976
Journal article
The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal
Psychopharmacologia, Vol.192(3), pp.385-396
2007
PMID: 17297634
Metrics
12 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.5 Neuroscience
- 1.5.420 Cortisol
- Web Of Science research areas
- Neurosciences
- Pharmacology & Pharmacy
- Psychiatry
- ESI research areas
- Neuroscience & Behavior
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites